Firestone Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Firestone Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-762	Closed	-$103K	–	451
2021 Q3	$103K	Hold	762	–	–	0.03%	163
2021 Q2	$103K	Hold	762	–	–	0.04%	158
2021 Q1	$103K	Hold	762	–	–	0.04%	158
2020 Q4	$107K	Hold	762	–	–	0.04%	148
2020 Q3	$85K	Hold	762	–	–	0.04%	149
2020 Q2	$85K	Hold	762	–	–	0.04%	146
2020 Q1	$59K	Hold	762	–	–	0.03%	167
2019 Q4	$72K	Buy	+762	New	+$65.9K	0.03%	173

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Firestone Capital Management's XBI Position: Q4 2021 in Review

Firestone Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 762 shares — an estimated $103K sold.

Firestone Capital Management first reported a position in XBI in Q4 2019 and held it in 8 quarters. The position peaked at $107K in Q4 2020. 700 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Firestone Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
Firestone Capital Management sold 762 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $103K.
Firestone Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 8 quarters.
Firestone Capital Management's State Street SPDR S&P Biotech ETF position peaked at $107K in Q4 2020.
700 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Firestone Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.